| Rank | Country | Trial sites | % of EU-27 total |
|---|---|---|---|
| 1 | Spain | 2,516 | 19.3% |
| 2 | France | 1,883 | 14.4% |
| 3 | Italy | 1,303 | 10.0% |
| 4 | Germany | 1,217 | 9.3% |
| 5 | Denmark | 1,052 | 8.1% |
| 6 | Belgium | 791 | 6.1% |
| 7 | Sweden | 725 | 5.6% |
| 8 | Netherlands | 700 | 5.4% |
| 9 | Poland | 477 | 3.7% |
| 10 | Portugal | 376 | 2.9% |
| 11 | Greece | 269 | 2.1% |
| 12 | Austria | 262 | 2.0% |
| 13 | Czechia | 224 | 1.7% |
| 14 | Finland | 218 | 1.7% |
| 15 | Ireland | 177 | 1.4% |
| 16 | Hungary | 165 | 1.3% |
| 17 | Romania | 117 | 0.9% |
| 18 | Bulgaria | 102 | 0.8% |
| 19 | Lithuania | 93 | 0.7% |
| 20 | Slovakia | 91 | 0.7% |
| 21 | Cyprus | 82 | 0.6% |
| 22 | Slovenia | 79 | 0.6% |
| 23 | Croatia | 59 | 0.5% |
| 24 | Latvia | 34 | 0.3% |
| 25 | Estonia | 31 | 0.2% |
| 26 | Luxembourg | 8 | 0.1% |
| 27 | Malta | 4 | 0.0% |
A study running in several countries is counted once in each, so the 27 country counts sum to 13,055 study-country combinations, more than the 10,079 distinct EU-27 studies. ClinicalTrials.gov is the main registry for US-based studies; many European studies are registered elsewhere, so these counts understate European trial activity. Overseas regions are not shown.
Source: Zacharis T. Physical Activity and Healthy Ageing & Longevity Data: Interoperability, Reuse, and Innovation in a Federated European Context. Open Research Europe, version 2, Figure 3 and Supplementary File S1. Search details: Extended Data, Section H (Zenodo).